Search results (10)
« Back to PublicationsOff-the-shelf dual CAR-iNKT cell immunotherapy eradicates medullary and leptomeningeal high-risk KMT2A-rearranged leukemia.
Journal article
Ren H. et al, (2026), Blood, 147, 180 - 196
Lead optimisation of OXS007417: in vivo PK profile and hERG liability modulation to optimise a small molecule differentiation agent for the potential treatment of acute myeloid leukaemia.
Journal article
Cogswell TJ. et al, (2024), RSC Med Chem, 15, 3495 - 3506
The Fetal Specific Gene LIN288 Is Essential for Human Fetal B-Lymphopoiesis and Initiation of KMT2A-AFF1+ Infant Acute Lymphoblastic Leukemia
Journal article
Ling RE. et al, (2024), BLOOD, 144, 199 - 200
The genome-wide impact of trisomy 21 on DNA methylation and its implications for hematopoiesis.
Journal article
Muskens IS. et al, (2021), Nat Commun, 12
H3K79me2/3 controls enhancer-promoter interactions and activation of the pan-cancer stem cell marker PROM1/CD133 in MLL-AF4 leukemia cells.
Journal article
Godfrey L. et al, (2021), Leukemia, 35, 90 - 106
The Origin of B-cells: Human Fetal B Cell Development and Implications for the Pathogenesis of Childhood Acute Lymphoblastic Leukemia.
Journal article
Jackson TR. et al, (2021), Front Immunol, 12
The BET inhibitor CPI203 promotes ex vivo expansion of cord blood long-term repopulating HSCs and megakaryocytes.
Journal article
Hua P. et al, (2020), Blood, 136, 2410 - 2415
novel human fetal liver-derived model reveals that MLL-AF4 drives a distinct fetal gene expression program in infant ALL
Journal article
Rice S. et al, (2020)
Urocortin suppresses endometrial cancer cell migration via CRFR2 and its system components are differentially modulated by estrogen.
Journal article
Owens GL. et al, (2017), Cancer Med, 6, 408 - 415
